Analysts expect Axsome Therapeutics, Inc. to report revenue of 238.14 M for Q3 26, against a range of 225.16 M to 251.11 M. The most recent reported quarter, Q2 26, came in at 216.35 M, a 6.9% miss against the 232.34 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 103.74 M | 118.77 M | 121.46 M | 150.04 M | 170.99 M | 194.69 M | 189.40 M | 216.35 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 109.50 M | 129.80 M | 119.52 M | 140.62 M | 183.88 M | 195.48 M | 209.92 M | 244.34 M | 251.11 M | 315.95 M | 301.80 M | 394.01 M | 377.09 M | 432.66 M | 532.45 M | 531.24 M | ||||||||||
| Low Estimate | 98.74 M | 115.51 M | 108.34 M | 119.58 M | 159.81 M | 165.93 M | 183.57 M | 220.34 M | 225.16 M | 295.32 M | 271.43 M | 327.32 M | 313.83 M | 361.40 M | 459.91 M | 452.48 M | ||||||||||
| Consensus Estimate | 104.12 M | 122.65 M | 113.93 M | 130.10 M | 171.84 M | 180.70 M | 196.74 M | 232.34 M | 238.14 M | 305.64 M | 286.61 M | 360.66 M | 345.46 M | 397.03 M | 496.18 M | 491.86 M |
Analysts expect Axsome Therapeutics, Inc. to report earnings per share of -0.56 for Q3 26, against a range of -0.60 to -0.52. The most recent reported quarter, Q2 26, came in at -0.99, a 15.1% miss against the -0.86 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.34 | -1.54 | -1.22 | -0.97 | -0.94 | -0.56 | -1.26 | -0.99 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.21 | -0.90 | -1.18 | -1.06 | -0.76 | -0.62 | -0.83 | -0.78 | -0.52 | -0.04 | -0.10 | 0.53 | 0.70 | 1.33 | 2.27 | 2.72 | ||||||||||
| Low Estimate | -1.41 | -0.98 | -1.40 | -1.16 | -0.84 | -0.68 | -0.91 | -0.94 | -0.60 | -0.04 | -0.10 | 0.47 | 0.58 | 1.13 | 1.99 | 2.48 | ||||||||||
| Consensus Estimate | -1.31 | -0.94 | -1.29 | -1.11 | -0.80 | -0.65 | -0.87 | -0.86 | -0.56 | -0.04 | -0.10 | 0.50 | 0.64 | 1.23 | 2.13 | 2.60 |
Pull Wall Street consensus for Axsome Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AXSM&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AXSM", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AXSM&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();